Health TrialsbyHealthPanel

Case Management Dyad

ConditionsHIVPre-exposure ProphylaxisCase ManagementContingency Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Chicago

About this trial

The overall goal of this study is to test whether dyadic and focused case management coupled with contingency management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of individuals living with HIV who are virally suppressed (viral suppression) when compared to routine Ryan White Non-Medical Case Management.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Dyadic Case Management

    Behavioral

    Subjects enrolled in the intervention arm will be offered focused case management centered around goal setting and future orientation. Subjects will be assigned two case managers to support their goals. Clients will receive conditional cash transfers for medical visit attendance and negative HIV/syphilis tests or undetectable viral loads.

Treatment groups

220 Participants
are divided into 2 treatment groups
Group A: Treatment as usualNo intervention 0 interventions
Group B: Dyadic Case ManagementExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Financial wellbeing

Proportion of subjects who report improved financial wellbeing (e.g. consistent income, ability to pay bills).

Time frame
18 months
2

Food Security

Proportion of individuals who report improved access to food (e.g. fewer gaps in access to food, reduced concern about access to food).

Time frame
18 months

Secondary outcomes

1

PrEP Persistence

Proportion of individuals who have engaged in PrEP care regularly (beyond 6 months).

Time frame
18 months
2

Viral Suppression

Proportion of individuals who have a viral load below 200 copies/mL

Time frame
18 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Chicago

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator

Source ClinicalTrials.gov
Apply now